Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas

被引:43
|
作者
Draelos, Zoe D. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
关键词
atopic dermatitis; calcineurin inhibitors; corticosteroids; pimecrolimus; sensitive; skin; tacrolimus;
D O I
10.1185/030079908X280419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background.-Atopic dermatitis (AD) is a common, chronic skin disorder characterized by itch and dry skin, which can develop into pruritic red plaques that ooze when scratched. AD flares often occur in anatomic areas where the skin is naturally thin (the face, neck, and intertriginous zones). Such regions, especially the face, are also areas of sensitive skin and need special consideration when being treated. Objective: This article will briefly review the concepts of thin and sensitive skin and discuss the treatment of AD in such areas. Methods: The MEDLINE database was searched for English-language articles published that contained the text terms atopic dermatitis, sensitive skin, treatment, topical corticosteroids, or topical calcineurin inhibitors. Articles that pertained to the safety and efficacy of various treatments were selected for further review. Results: Topical corticosteroids (TCSs) are effective for the treatment of AD in thin and sensitive skin areas, but their use is limited due to adverse events, such as skin thinning, and the potential for impairing the skin barrier. Topical calcineurin inhibitors (TCls) also provide effective AD treatment without impairing the skin barrier or inducing skin thinning. Although TCls may be associated with a higher incidence of applicationsite reactions such as pruritus and skin burning, these symptoms are typically transient and mild to moderate in nature. Limitations: This analysis focused primarily on relatively recent key trials evaluating the treatment of AD in sensitive skin; due to the limited number of controlled trials evaluating TCS agents, consensus statements and comprehensive review articles were used for most of the information pertaining to this therapeutic option. Conclusions: Although both TCSs and TCls have a place in a long-term, comprehensive treatment strategy for AD, TCls may have a particular use in thin and sensitive skin areas.
引用
收藏
页码:985 / 994
页数:10
相关论文
共 50 条
  • [41] A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas
    Reda, Ashraf M.
    Elgendi, Ayman
    Ebraheem, Ahmed Ismail
    Aldraibi, Mohammed S.
    Qari, Mohammed Saleh
    Abdulghani, Magdy Mohammad R.
    Luger, Thomas
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (04) : 366 - 373
  • [42] Impact of Topical Calcineurin Inhibitors on Quality of Life in Patients with Atopic Dermatitis
    John R. Ingram
    Julie A. Martin
    Andrew Y. Finlay
    American Journal of Clinical Dermatology, 2009, 10 : 229 - 237
  • [43] Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis
    Hillary C. Frankel
    Abrar A. Qureshi
    American Journal of Clinical Dermatology, 2012, 13 : 113 - 123
  • [44] Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies
    Thaci, Diamant
    Salgo, Rebekka
    CLINICS IN DERMATOLOGY, 2010, 28 (01) : 52 - 56
  • [45] Impact of Topical Calcineurin Inhibitors on Quality of Life in Patients with Atopic Dermatitis
    Ingram, John R.
    Martin, Julie A.
    Finlay, Andrew Y.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2009, 10 (04) : 229 - 237
  • [46] Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis
    Frankel, Hillary C.
    Qureshi, Abrar A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (02) : 113 - 123
  • [47] Topical Corticosteroids in Treatment of Atopic Dermatitis: An Overview of Their Current Status
    Sharma, Kusha
    Tharmatt, Abhay
    Salooria, Shivali
    Sharma, Rashi
    Bedi, Neena
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (38)
  • [48] Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroids
    Lewis, Daniel J.
    Feldman, Steven R.
    PEDIATRIC DERMATOLOGY, 2018, 35 (02) : 278 - 279
  • [49] The future of topical JAK inhibitors in the treatment of atopic dermatitis
    Mazgaj, Joanna
    Kotewicz, Magdalena
    Jaworek, Andrzej
    Szepietowski, Jacek C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
  • [50] Comparative trial of topical corticosteroids in atopic dermatitis
    Uenishi, T
    Sugiura, H
    Tanaka, T
    Uehara, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : 607 - 607